The NationArtificial hearts may help patients survive until transplantMedical XpressThe largest single-center study of patients implanted with a total artificial heart finds the device may help patients in severe heart failure survive until they can re…
J Walk'N Organ Donor Registry Drive returns next Saturday – St. Louis American
|
J Walk’N Organ Donor Registry Drive returns next Saturday
St. Louis American Organ Donor Registry Drive is more than a walk-a-thon– it’s a challenge to the students of America to be mindful of the power of organ donation. J Walk’N is named in honor of the late Justin Hughes (son of Vanessa Hughes and brother of former NBA star … |
MAB Discovery to Produce Antibodies for Genmab – Genetic Engineering News
MAB Discovery to Produce Antibodies for GenmabGenetic Engineering NewsMunich, Germany-based company MAB Discovery has cut a deal with Genmab and its affiliate Genmab BV, under which it will produce antibodies for multiple Genmab targets to help Genmab …
Could Inadequate Sleep Cause Irreversible Brain Death? – Everyday Health
Could Inadequate Sleep Cause Irreversible Brain Death?Everyday HealthSeveral recent studies have demonstrated the relationship of sleep to brain function. In particular, how we need sleep for normal brain function. In a recent study, a system called th…
Lions Club to promote organ donation – Petoskey News-Review
Lake Wylie Pilot |
Lions Club to promote organ donation
Petoskey News-Review Michigan Secretary of State offices will on Wednesday, April 2, join with the agency’s partners at Gift of Life and the Michigan Eye Bank to encourage residents to get a heart — on their driver’s license — if they add their name to the Michigan Organ … BBCHS senior wins statewide poster contest promoting organ donationKankakee Daily Journal |
Research and Markets: Therapy Class Overview: Rituximab Biosimilar – Business Wire (press release)
|
Research and Markets: Therapy Class Overview: Rituximab Biosimilar
Business Wire (press release) Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson’s Remicade, which is approved for RA, Crohn’s disease and several … |
RuiYi declares $15M Series B financing to advance monoclonal antibodies … – News-Medical.net
RuiYi declares $15M Series B financing to advance monoclonal antibodies …News-Medical.netRuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent cor…
Cord Blood Registry's Newborn Possibilities Program – PR Newswire (press release)
|
Cord Blood Registry’s Newborn Possibilities Program
PR Newswire (press release) For families that have been identified with a qualifying medical condition currently treatable with a cord blood stem cell transplant or a high-risk pregnancy, the Newborn Possibilities Program provides no-cost newborn stem cell processing and five … |
Samsung unveils Galaxy S5 in India, available from April 11 – Times of India
Times of India |
Samsung unveils Galaxy S5 in India, available from April 11
Times of India The device has a 2800mAh battery. The three key features in Galaxy S5 are finger-print scanner, a heart-rate sensor and the new body that is water and dust proof. In the market, Galaxy S5 will go against the next generation of top end smartphones from … Samsung Gear Fit, Gear 2, and Gear 2 Neo India price revealedNDTV Samsung Galaxy S5 Launched in India; Price, Specification DetailsInternational Business Times, India Edition Samsung Galaxy S5 price in India between Rs 51000-Rs 53000, to be available …BGR India IBNLive –Daily News & Analysis –Businessworld all 510 news articles » |
RuiYi Announces $15 Million Series B to Advance Pipeline of Therapeutic … – MarketWatch
|
RuiYi Announces $15 Million Series B to Advance Pipeline of Therapeutic …
MarketWatch RuiYi has a pipeline of innovative monoclonal antibodies to previously untargeted G protein coupled receptors (GPCRs) for important global, therapeutic needs. The financing will support the continued development of RuiYi’s lead asset, RYI-008, a novel … San Diego’s RuiYi Raises $15M for Pipeline of Biologic TherapeuticsXconomy RuiYi banks $15M from A-list backers to amp up Chinese R&DFierceBiotech |